Health Canada is warning consumers not to use the unauthorized product Vigorect Oral Gel Shooter, considering it contains an undeclared drug substance tadalafil, which should only be available by prescription. The use of Vigorect Oral Gel Shooter could pose serious health risks, particularly for patients...

Patients taking medications to treat bipolar disorder are increasingly likely to get well faster and stay well whether they get intensive psychotherapy, according to results from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), funded by the National Institutes of Health’s...

Eurand, a global specialty pharmaceutical company, nowadays unveiled notes from two phase III clinical trials on its lead product candidate, Zentase(TM), previously EUR-1008, for the treatment of Exocrine Pancreatic Insufficiency (EPI). The US Food and Drug Administration (FDA) granted fast track status...

Cerimon Pharmaceuticals, Inc., announced nowadays it has begun enrolling patients in a Phase 2b clinical study, for its lead product candidate basiliximab (Simulect(R)), titled ARREST UC-1 (Achieve Remission & Reduce or Eliminate Steroid Therapy in Ulcerative Colitis) for the treatment of ulcerative...

EndoGastric Solutions, the world leader in endoluminal intragastric surgery, is pleased to announce that it has received clearance from the US FDA for its StomaphyX device. StomaphyX is indicated for use in endoluminal transoral tissue approximation and ligation in the GI tract. “This is a major...

Genetics tests could help supply cystic fibrosis (CF) patients with targeted treatment in future, pilot study authors propose. Results from a French clinical trial published nowadays in BMC Medicine show how a small percentage of CF sufferers with a rare genetic stop mutation responded positively to...